Anti-SARS-CoV-2 IgG levels are associated with circulating levels of chemokines CXCL9/CXCL10 and severity disease, but not with RBD-specific B cells 4 months after COVID-19

Quiroga, RA; Novoa, SAS; Cabrera-Garcia, CD; Cáceres, BEA; Munoz C.P.; Llerena F.; Fraga M.; Henríquez M; Labarca G.; Nova-Lamperti E.; Colombo A.; Fernandez, LL

Más información

Título según WOS: Anti-SARS-CoV-2 IgG levels are associated with circulating levels of chemokines CXCL9/CXCL10 and severity disease, but not with RBD-specific B cells 4 months after COVID-19
Volumen: 210
Número: 1
Fecha de publicación: 2023
Idioma: English
Notas: ISI